These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8061666)

  • 1. Does flexible ureteropyeloscopy promote local recurrence of transitional cell carcinoma?
    Kulp DA; Bagley DH
    J Endourol; 1994 Apr; 8(2):111-3. PubMed ID: 8061666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ureteropyeloscopy in the diagnosis of patients with upper tract hematuria: an initial clinical study.
    Yazaki T; Kamiyama Y; Tomomasa H; Shimizu H; Okano Y; Iiyama T; Iizumi T; Umeda T
    Int J Urol; 1999 May; 6(5):219-25. PubMed ID: 10375183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endourologic treatment of renal pelvic and ureteral transitional cell carcinoma.
    Gerber GS; Steinberg GD
    Tech Urol; 1999 Jun; 5(2):77-80. PubMed ID: 10458659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of the treatment of carcinoma of the renal pelvis and ureter].
    Maruoka M; Miyauchi T; Nagayama T
    Hinyokika Kiyo; 1989 Oct; 35(10):1673-7. PubMed ID: 2610174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact factors on prognosis of patients with pT3 upper urinary tract transitional cell carcinoma.
    Wu CF; Pang ST; Chen CS; Chuang CK; Chen Y; Lin PY
    J Urol; 2007 Aug; 178(2):446-50, dicussion 450. PubMed ID: 17561129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ureteroscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys.
    Chen GL; Bagley DH
    J Urol; 2000 Oct; 164(4):1173-6. PubMed ID: 10992360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of renal pelvic carcinoma in a completely duplicated pelvis and ureter].
    Tamada H; Tamura T; Kaneko T; Takata K; Sakuma T; Suzuki Y
    Hinyokika Kiyo; 1998 Oct; 44(10):733-5. PubMed ID: 9850840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous management of renal pelvic urothelial tumors: long-term followup.
    Goel MC; Mahendra V; Roberts JG
    J Urol; 2003 Mar; 169(3):925-9; discussion 929-30. PubMed ID: 12576814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imperative indications for conservative management of upper tract transitional cell carcinoma.
    Krambeck AE; Thompson RH; Lohse CM; Patterson DE; Elliott DS; Blute ML
    J Urol; 2007 Sep; 178(3 Pt 1):792-6; discussion 796-7. PubMed ID: 17632132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ureteroscopic treatment and surveillance of upper urinary tract transitional cell carcinoma.
    Keeley FX; Bibbo M; Bagley DH
    J Urol; 1997 May; 157(5):1560-5. PubMed ID: 9112476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrograde endoscopic laser therapy and ureteroscopic surveillance for transitional cell carcinoma of the upper urinary tract.
    Mugiya S; Ozono S; Nagata M; Otsuka A; Takayama T; Nagae H
    Int J Urol; 2006 Jan; 13(1):1-6. PubMed ID: 16448423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys.
    Thompson RH; Krambeck AE; Lohse CM; Elliott DS; Patterson DE; Blute ML
    Urology; 2008 Apr; 71(4):713-7. PubMed ID: 18267338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience.
    Cutress ML; Stewart GD; Wells-Cole S; Phipps S; Thomas BG; Tolley DA
    BJU Int; 2012 Dec; 110(11):1608-17. PubMed ID: 22564677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic diagnosis and treatment of chronic unilateral hematuria of uncertain etiology.
    Kumon H; Tsugawa M; Matsumura Y; Ohmori H
    J Urol; 1990 Mar; 143(3):554-8. PubMed ID: 2304168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome after percutaneous treatment of transitional cell carcinoma of the renal pelvis.
    Patel A; Soonawalla P; Shepherd SF; Dearnaley DP; Kellett MJ; Woodhouse CR
    J Urol; 1996 Mar; 155(3):868-74. PubMed ID: 8583595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic versus laparoscopic management of noninvasive upper tract urothelial carcinoma: 20-year single center experience.
    Cutress ML; Stewart GD; Tudor EC; Egong EA; Wells-Cole S; Phipps S; Thomas BG; Riddick AC; McNeill SA; Tolley DA
    J Urol; 2013 Jun; 189(6):2054-60. PubMed ID: 23228378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic management of upper urinary tract transitional cell carcinoma: long-term experience.
    Daneshmand S; Quek ML; Huffman JL
    Cancer; 2003 Jul; 98(1):55-60. PubMed ID: 12833455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma.
    Kim DS; Lee YH; Cho KS; Cho NH; Chung BH; Hong SJ
    Urology; 2010 Feb; 75(2):328-32. PubMed ID: 20018349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative radiation therapy in 26 patients with invasive transitional cell carcinoma of the upper urinary tract: no impact on survival?
    Maulard-Durdux C; Dufour B; Hennequin C; Chrétien Y; Vignes B; Droz D; Delanian S; Housset M
    J Urol; 1996 Jan; 155(1):115-7. PubMed ID: 7490805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract.
    Terakawa T; Miyake H; Muramaki M; Takenaka A; Hara I; Fujisawa M
    Urology; 2008 Jan; 71(1):123-7. PubMed ID: 18242379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.